REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/20/2026
Back to search
Official data from USPTO
PHARMFILM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
07/20/2026
Trademark type
Word
Nice classes
5
Filing date
10/15/2020
Registration date
07/20/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/20/2021
Last transaction
07/20/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
12/01/2008
First use in commerce
12/01/2008
Drawing code
4
Owner type
03
Owner location
Warren, NJ, US
Examiner
MCNAMARA, SHANA MARIE
Law office
N70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Aquestive Therapeutics, Inc.
Representatives
Carrie Webb Olson DAY PITNEY LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Films dissolvable in the mouth for the oral delivery of drugspharmaceuticals and dietary supplements to humans; Dissolvable polymer films as a base in preparations for oralsublingualbuccaltransmucosal delivery of pharmaceutically active ingredients; Drug delivery platform technologydrug delivery agents consisting of compounds that facilitateenhance or promote optimized deliverydosing management and accuracyenhanced solubilityenhanced permeabilityenhanced absorption of a wide range of pharmaceutical agents; pharmaceutical preparationsoralsublingualbuccaltransmucosal delivery enhancement agents to facilitateenhancepromote optimized deliverydosing management and accuracyenhanced solubilityenhanced permeability or enhanced absorption of a variety of pharmaceutical agents
Publications
History of USPTO decisions and trademark events.
23 publications found
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
07/26/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/26/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/26/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/26/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/26/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/26/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/25/2022
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
08/25/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/25/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/25/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
07/20/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/04/2021
PUBO
PUBLISHED FOR OPPOSITION
05/04/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/14/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/26/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
03/26/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/26/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
03/26/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/26/2021
DOCK
ASSIGNED TO EXAMINER
03/15/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/03/2020
NWAP
NEW APPLICATION ENTERED
10/19/2020
Continuous trademark protection
Get notified about every new filing that threatens PHARMFILM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.